共 50 条
Advances in the Medical Management of Vascular Anomalies
被引:24
|作者:
Ricci, Kiersten W.
[1
]
机构:
[1] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Div Hematol, Hemangioma & Vasc Malformat Ctr, Cincinnati, OH 45229 USA
关键词:
vascular anomaly;
vascular malformation;
sirolimus;
propranolol;
timolol;
interventional radiology;
HEREDITARY HEMORRHAGIC TELANGIECTASIA;
INVOLUTING CONGENITAL HEMANGIOMA;
KASABACH-MERRITT PHENOMENON;
PULSED DYE-LASER;
SUPERFICIAL INFANTILE HEMANGIOMAS;
BLEB NEVUS SYNDROME;
KAPOSIFORM HEMANGIOENDOTHELIOMA;
TOPICAL TIMOLOL;
VENOUS MALFORMATION;
TUFTED ANGIOMA;
D O I:
10.1055/s-0037-1604297
中图分类号:
R8 [特种医学];
R445 [影像诊断学];
学科分类号:
1002 ;
100207 ;
1009 ;
摘要:
Vascular anomalies comprise a spectrum of diseases that are broadly classified as tumors and malformations. Diagnosis is often challenging, given a wide range of clinical presentations with overlapping signs and symptoms. Accurate diagnosis is critical to determine prognosis and to generate a management plan, which frequently involves multiple subspecialists during different phases of treatment. An updated classification system provides structure and clear, consistent terminology, allowing for improved diagnosis, provider communication, and collaboration. Historically, treatment of vascular anomalies was primarily surgical and medical therapies were limited or ineffective. Recent discoveries of pharmacologic agents effective in treating vascular anomalies. have broadened our medical therapeutic options, limiting the need for unnecessary or high-risk procedures and improving patients' quality of life.
引用
收藏
页码:239 / 249
页数:11
相关论文